WTO’s Latest Vaccine Waiver Talk: A Bit of Sweet Success, With a Dash of Drama
Good news, folks! The WTO’s first meeting on a temporary waiver of intellectual property rights for Covid‑19 vaccines was “very well” — according to its chair, Ambassador Lansana Gberie of Sierra Leone. Despite a few raised eyebrows, no member slammed the draft outright.
What the Draft Is Trying to Do
After months of back‑and‑forth between the USA, EU, India, and South Africa, this “outcome document” is the fresh sugar‑coated version everyone hopes will slide into a final deal. Gberie told Reuters that most delegations see it as a solid starting point: “It could turn into a negotiating text, and that’s the path we need to go down.”
Voices of Concern
- Some delegates felt the proposal is too “narrow” – it focuses solely on vaccines, leaving out other medical innovations.
- China, while broadly cheering the idea, accused the draft of a “unreasonable and arbitrary criterion” that could snub it because of its high share of vaccine exports.
- Britain, Switzerland, and other wealthy nations warn that the waiver might dent the incentives for pharma research.
In a nutshell, the draft has a few loose ends that need tying up. A consensus‑based vote, with any member wielding a veto, decides its fate.
What This Means for the Global Trade Body
WTO Director‑General Ngozi Okonjo‑Iweala, who has been shepherding the negotiations, insists a deal by next month’s ministerial conference is “hugely important.” A single delegate described Friday’s session as the moment when the agreement would “float or sink.”
A whisper among some delegates hinted that the lack of public backing from the primary negotiating parties has shaken confidence. Still, the draft moves forward with cautious optimism.
Bottom Line (in a nutshell)
While the draft has been accepted by most for now, the road to a final e‑signature involves a lot of coalition‑building, careful wording tweaks, and keeping the big pharma engines humming. Almost everyone sees potential, but a few hold important reservations that could shape the final shape of the waiver.
